Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1777 of 6351
-
New study aims to tame skin rashes in lung cancer therapy
Disease control OngoingThe purpose of this study is to evaluate whether enhanced dermatologic management can reduce incidence of grade greater than or equal to (\>=) 2 dermatologic adverse events of interest (DAEIs) when compared with standard-of-care skin management and with modified enhanced dermatol…
Phase 2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New scan could spot Parkinson's protein in the brain
Diagnosis Recruiting nowThe current protocol is to determine the biodistribution, metabolism, excretion and brain uptake of 11C-M503. The goal of this radiotracer is to quantify alpha-synuclein that is abnormally deposited in the brain of people with Parkinson's disease (PD). Investigators will compare …
Early phase 1 • Sponsor: University of Pennsylvania • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
New drug could cool menopause hot flashes without hormones
Symptom relief CompletedHot flashes are the most common reason women going through menopause seek medical attention. Hormone replacement therapy, or HRT, is most often prescribed to treat hot flashes. However, HRT can't be used by all women or for as long as may be needed. Researchers want to find othe…
Phase 3 • Sponsor: Astellas Pharma Inc • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Can a simple test predict ovarian cancer treatment success?
Knowledge-focused Recruiting nowThe study concerns patients with Invasive epithelial ovarian cancer, primary Fallopian tube carcinoma, ovarian-type peritoneal carcinoma, and with an indication of a first-line platinum-based chemotherapy. To determine HRD status, 2 separate tests will be performed in the study:…
Phase 2 • Sponsor: Centre Francois Baclesse • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:47 UTC
-
Weekly shot could replace daily insulin for diabetes
Disease control CompletedThis study will compare the new medicine IcoSema, which is a combination of insulin icodec and semaglutide, taken once a week, to insulin glargine (mentioned as insulin glargine in this form) taken daily in people with type 2 diabetes. The study will look at how well IcoSema cont…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Could a Brain-Boosting pill lift depression?
Symptom relief CompletedThis study will evaluate of the efficacy and safety of SPN-820 in Adults With Major Depressive Disorder (MDD)
Phase 2 • Sponsor: Navitor Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Shock device may free ICU patients from ventilators faster
Symptom relief CompletedThe objective of this study is to evaluate the efficacy of the VentFree Respiratory Muscle Stimulator (VentFree) in critically ill adult patients who require invasive mechanical ventilation, when compared to sham.
Sponsor: Liberate Medical • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Could a blood vessel blocker boost esophageal cancer treatment?
Disease control CompletedThis is an open-label, randomized, controlled phase II study evaluating induction immuno-chemotherapy and concurrent chemoradiotherapy with or without apatinib in unresectable, locally advanced esophageal squamous cell carcinoma
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Stem cell jab could replace surgery for painful thumb arthritis
Disease control Recruiting nowRhizarthosis is a common disease in the population (15%). It has a major impact on the function of the hand since it compromises the pollicidigitales claws and all gripping functions with the thumb. However, no curative medical treatment exists to date. The treatment is initially…
Phase 2 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New app aims to curb violence and drug use in black youth
Prevention OngoingThis study will adapt and test a culturally tailored, multi-component, and trauma-focused digital intervention to reduce the risk and effects of youth violence and substance use and bridge service access gaps for young Black males (YBM) in pediatric emergency and community-based …
Sponsor: Rush University Medical Center • Aim: Prevention
Last updated Jun 27, 2026 12:24 UTC
-
Can a phone app curb binge drinking? new study puts digital screening to the test
Disease control CompletedThis epidemiological study (randomized clinical trial) aims to evaluate a digital Screening and Brief Intervention (e-SBI) system for reducing and preventing harmful alcohol consumption in patients treated by the Brazilian Unified Health System (SUS), compared to an in-person SBI…
Sponsor: InCor Heart Institute • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Can a simple abutment preserve bone and gums after tooth extraction?
Disease control CompletedThis study aimed to evaluate bone and soft tissue changes clinically and radio-graphically after using socket sealing abutment with or without bone graft material.
Sponsor: Mansoura University • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Pocket-Sized AI device could revolutionize cervical cancer screening in kenya
Diagnosis Recruiting nowThe Pocket colposcope has 510k FDA clearance and has been successfully used in \~2500 unique patients globally in Duke and non-Duke protocols to date. 1054 women who are HPV(+) and planned to undergo treatment at four Ministry of Health-supported outpatient clinics in Kisumu Coun…
Sponsor: Duke University • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC
-
New MRI dye aims to sharpen prostate cancer detection
Diagnosis PausedThe fundamental aim of this study is to show that the novel contrast agent Gadopiclenol (Elucirem), with its high relaxivity, facilitates increased contrast enhancement and improved differentiation of clinically significant prostate cancer on Prostate MRI, as categorized by the P…
Phase 4 • Sponsor: Columbia University • Aim: Diagnosis
Last updated Jul 22, 2026 00:00 UTC
-
Radioactive lipiodol takes aim at inoperable liver tumors
Disease control Stopped earlyThe goal of this monocentric interventional study is to evaluate the efficacy, in terms of objective response rate, of the 188Re-SSS lipiodol SIRT in patients with non-operable HCC.
Phase 2 • Sponsor: Center Eugene Marquis • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Mind over matter: Acceptance-Based coaching may help teens shed pounds
Disease control Recruiting nowThe goal of this clinical trial is to learn about cardiovascular disease risk among adolescent girls with overweight/obesity. The main questions this trial aims to answer are: 1. Does an acceptance-based healthy lifestyle intervention demonstrate more weight loss than a health e…
Sponsor: Nemours Children's Clinic • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New Antibody-Like drug joins forces with standard chemo to fight lung cancer
Disease control OngoingThis study is open to adults with extensive stage small cell lung cancer. The study is in people with advanced cancer that are eligible for standard of care including chemotherapy and anti-PD-L1 (Programmed Cell Death Ligand 1) immunotherapy. The purpose of this study is to find…
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Home workouts with live coaching could ease cancer side effects
Symptom relief Recruiting nowBackground Many people with cancer face ongoing problems from their disease and treatments, like fatigue, reduced physical fitness, feeling anxious or down, and neuropathy. While exercise might help with these problems, most studies did not focus on tailoring exercise to address…
Sponsor: UMC Utrecht • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
New drug combo takes on tough lung cancer
Disease control OngoingThis study is open to adults with extensive stage small cell lung cancer. The study is in people with advanced cancer that had previously received platinum-based chemotherapy and are eligible to receive a single agent chemotherapy treatment. The purpose of this study is to find …
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can a laser boost the benefits of deep gum cleaning?
Disease control CompletedThis study compared SRP alone and SRP combined with LANAP in 120 patients with chronic periodontitis. Clinical outcomes and oral health-related quality of life (OHRQoL) were assessed before and 12 weeks after treatment. The study aimed to determine how these treatments affect bot…
Sponsor: Mahe Nigar • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC